Status: Recruiting
Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders
PMCF study to further substantiate the effectiveness and safety of OSTENIL® TENDON in the overall as well as indication-specific treatment of pain and restricted mobility in four different tendon disorders (patella tendon, peroneal tendon, medial epicondylus humeri and iliotibial band) in a real-life clinical setting when used according to the instructions for use.
Participants needed: 84
Trial details
Age: 18-99Biological sex: AllType: ObservationalSponsor: TRB Chemedica AGUpdated: Jul 2, 2026Locations: 5
Eligibility criteria
Patient aged between 18 and 99 years [+3]
Presence of any contra-indication or precautionary condition listed in the instr... [+15]